YIBO LI: Open Payments
NPI 1861077299 · CHICAGO, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,044 in 28 payments from 18 companies in 2025. Trend: 2023 $349 · 2024 $1,048 · 2025 $2,044
Food & beverage: $2,044
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 2 | $235 |
| Lilly USA, LLC | 2 | $196 |
| Gilead Sciences, Inc. | 3 | $178 |
| Amgen Inc. | 2 | $158 |
| Phathom Pharmaceuticals, Inc. | 1 | $150 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $149 |
| Novo Nordisk Inc | 2 | $147 |
| Madrigal Pharmaceuticals | 1 | $142 |
| BridgeBio Pharma, Inc. | 1 | $133 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $121 |
Products named: VOQUEZNA, ENTYVIO, Wegovy, REZDIFFRA, Attruby, REPATHA, Biktarvy, JARDIANCE.
Industry payments across IL — which companies pay providers there.
